Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

5-methyl-pyridine-2-sulfonic acid {6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-[2-(1H-tetrazol-5-yl)-pyridin-4-yl]-pyrimidin-4-yl}-amide sodium salt

EU orphan designation number: EU/3/03/182   
Active ingredient: 5-methyl-pyridine-2-sulfonic acid {6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-[2-(1H-tetrazol-5-yl)-pyridin-4-yl]-pyrimidin-4-yl}-amide sodium salt
Indication: Treatment of aneurysmal subarachnoid haemorrhage
Sponsor: Actelion Registration Ltd
Chiswick Tower, 13th floor, 389 Chiswick High Road, London W4 4AL, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2003 Orphan designation EMEA/OD/057/03 (2003)5039 of 12/12/2003
10/01/2005 Transfer of orphan designation EMEA/OD/057/03/T/01 (2004)5731 of 06/01/2005
02/07/2014 Change of name and/or address of sponsor